JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

3.47 12.3

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.01

Max

3.59

Schlüsselkennzahlen

By Trading Economics

Einkommen

-408M

-429M

Verkäufe

-11M

469M

Gewinnspanne

-91.554

Angestellte

4,200

EBITDA

-374M

-360M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+64.22% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

5.9M

327M

Vorheriger Eröffnungskurs

-8.83

Vorheriger Schlusskurs

3.47

Nachrichtenstimmung

By Acuity

13%

87%

25 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Apr. 2026, 23:15 UTC

Wichtige Nachrichtenereignisse

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27. Apr. 2026, 23:08 UTC

Ergebnisse
Wichtige Markttreiber

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27. Apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27. Apr. 2026, 23:34 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27. Apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27. Apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27. Apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27. Apr. 2026, 22:10 UTC

Ergebnisse

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27. Apr. 2026, 21:56 UTC

Ergebnisse

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27. Apr. 2026, 21:44 UTC

Ergebnisse

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27. Apr. 2026, 21:43 UTC

Ergebnisse

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27. Apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27. Apr. 2026, 20:39 UTC

Ergebnisse

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

64.22% Vorteil

12-Monats-Prognose

Durchschnitt 5.14 USD  64.22%

Hoch 8 USD

Tief 3 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

12

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

25 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat